Oncology & Cancer

Metabolic enzyme promotes neuroblastoma aggressiveness

High-risk neuroblastoma is an aggressive childhood cancer with poor treatment outcomes. Despite intensive chemotherapy and radiotherapy, less than 50 percent of these children survive for five years. While the genetics of ...

Medical research

A novel radioisotope therapy for children with neuroblastoma

Researchers from Kanazawa University retrospectively analyzed children with refractory or relapsed high-risk neuroblastoma who were treated with high-dose 131I-metaiodobenzylguanidine at Kanazawa University Hospital. They ...

Oncology & Cancer

More children survive neuroblastoma

Both the survival rate and the incidence of neuroblastoma have increased in recent years, as was shown by a study from the Princess Máxima Center. The improved chance of survival and the increase in the number of patients ...

page 1 from 2